Literature DB >> 11375216

Continuous subcutaneous insulin infusion in type 1 diabetes.

J Pickup, H Keen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375216      PMCID: PMC1120370          DOI: 10.1136/bmj.322.7297.1262

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  12 in total

1.  Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.

Authors:  K Dahl-Jørgensen; O Brinchmann-Hansen; K F Hanssen; T Ganes; P Kierulf; E Smeland; L Sandvik; O Aagenaes
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

2.  Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes.

Authors:  B W Bode; R D Steed; P C Davidson
Journal:  Diabetes Care       Date:  1996-04       Impact factor: 19.112

3.  Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.

Authors:  E A Boland; M Grey; A Oesterle; L Fredrickson; W V Tamborlane
Journal:  Diabetes Care       Date:  1999-11       Impact factor: 19.112

4.  Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII.

Authors:  V A Koivisto; H Yki-Järvinen; E Helve; S L Karonen; R Pelkonen
Journal:  Diabetes       Date:  1986-01       Impact factor: 9.461

5.  Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience.

Authors:  E Chantelau; M Spraul; I Mühlhauser; R Gause; M Berger
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

6.  Hypoglycemic coma associated with subcutaneous insulin infusion by portable pump.

Authors:  D R Lock; L A Rigg
Journal:  Diabetes Care       Date:  1981 May-Jun       Impact factor: 19.112

7.  Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients.

Authors:  R S Mecklenburg; E A Benson; J W Benson; P N Fredlund; T Guinn; R J Metz; R L Nielsen; C A Sanner
Journal:  JAMA       Date:  1984-12-21       Impact factor: 56.272

8.  Implementation of treatment protocols in the Diabetes Control and Complications Trial.

Authors: 
Journal:  Diabetes Care       Date:  1995-03       Impact factor: 19.112

9.  Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti
Journal:  Br Med J       Date:  1978-01-28

10.  Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Audit of medical care.

Authors:  J J Bending; J C Pickup; H Keen
Journal:  Am J Med       Date:  1985-12       Impact factor: 4.965

View more
  6 in total

1.  Risks with continuous subcutaneous insulin infusion can be serious.

Authors:  G Knight
Journal:  BMJ       Date:  2001-09-22

2.  Insulin pumps.

Authors:  T Torrance; V Franklin; S Greene
Journal:  Arch Dis Child       Date:  2003-11       Impact factor: 3.791

3.  Continuous subcutaneous insulin infusion versus multiple daily injections.

Authors:  P Karagianni; Ch Sampanis; Ch Katsoulis; Gr Miserlis; S Polyzos; I Zografou; S Stergiopoulos; I Douloumbakas; Ch Zamboulis
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

4.  Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials.

Authors:  John Pickup; Martin Mattock; Sally Kerry
Journal:  BMJ       Date:  2002-03-23

5.  Feeding problems reported by parents of young children with type 1 diabetes on insulin pump therapy and their associations with children's glycemic control.

Authors:  Susana R Patton; Laura B Williams; Lawrence M Dolan; Ming Chen; Scott W Powers
Journal:  Pediatr Diabetes       Date:  2009-03-11       Impact factor: 4.866

6.  Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.